GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Surmodics Inc (STU:SU6) » Definitions » Cyclically Adjusted PS Ratio

Surmodics (STU:SU6) Cyclically Adjusted PS Ratio : 5.53 (As of Jun. 17, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Surmodics Cyclically Adjusted PS Ratio?

As of today (2024-06-17), Surmodics's current share price is €38.80. Surmodics's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €7.02. Surmodics's Cyclically Adjusted PS Ratio for today is 5.53.

The historical rank and industry rank for Surmodics's Cyclically Adjusted PS Ratio or its related term are showing as below:

STU:SU6' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 2.49   Med: 5.53   Max: 15.92
Current: 5.34

During the past years, Surmodics's highest Cyclically Adjusted PS Ratio was 15.92. The lowest was 2.49. And the median was 5.53.

STU:SU6's Cyclically Adjusted PS Ratio is ranked worse than
73.58% of 477 companies
in the Medical Devices & Instruments industry
Industry Median: 2.12 vs STU:SU6: 5.34

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Surmodics's adjusted revenue per share data for the three months ended in Mar. 2024 was €2.073. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €7.02 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Surmodics Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Surmodics's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Surmodics Cyclically Adjusted PS Ratio Chart

Surmodics Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.07 7.31 9.24 4.43 4.24

Surmodics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.20 4.21 4.24 4.77 3.73

Competitive Comparison of Surmodics's Cyclically Adjusted PS Ratio

For the Medical Devices subindustry, Surmodics's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Surmodics's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Surmodics's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Surmodics's Cyclically Adjusted PS Ratio falls into.



Surmodics Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Surmodics's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=38.80/7.02
=5.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Surmodics's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Surmodics's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=2.073/131.7762*131.7762
=2.073

Current CPI (Mar. 2024) = 131.7762.

Surmodics Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.779 100.560 1.021
201409 0.860 100.428 1.128
201412 0.858 99.070 1.141
201503 1.008 99.621 1.333
201506 1.068 100.684 1.398
201509 1.173 100.392 1.540
201512 1.152 99.792 1.521
201603 1.137 100.470 1.491
201606 1.338 101.688 1.734
201609 1.219 101.861 1.577
201612 1.252 101.863 1.620
201703 1.219 102.862 1.562
201706 1.183 103.349 1.508
201709 1.261 104.136 1.596
201712 1.100 104.011 1.394
201803 1.148 105.290 1.437
201806 1.441 106.317 1.786
201809 1.487 106.507 1.840
201812 1.414 105.998 1.758
201903 1.456 107.251 1.789
201906 1.570 108.070 1.914
201909 2.029 108.329 2.468
201912 1.478 108.420 1.796
202003 1.502 108.902 1.817
202006 1.732 108.767 2.098
202009 1.375 109.815 1.650
202012 1.341 109.897 1.608
202103 2.103 111.754 2.480
202106 1.432 114.631 1.646
202109 1.447 115.734 1.648
202112 1.467 117.630 1.643
202203 1.703 121.301 1.850
202206 1.688 125.017 1.779
202209 1.883 125.227 1.981
202212 1.683 125.222 1.771
202303 1.811 127.348 1.874
202306 3.442 128.729 3.523
202309 1.863 129.860 1.890
202312 1.987 129.419 2.023
202403 2.073 131.776 2.073

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Surmodics  (STU:SU6) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Surmodics Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Surmodics's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Surmodics (STU:SU6) Business Description

Traded in Other Exchanges
Address
9924 West 74th Street, Eden Prairie, MN, USA, 55344
Surmodics Inc is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. The company's mission is to improve the treatment and detection of disease by using its technology to provide solutions to difficult medical devices and diagnostic challenges. It has two reportable segments: Medical device unit; Manufacture of performance coatings, including surface modification coating technologies and the Vitro diagnostics unit; Manufacture of chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets. Surmodics derives majority of its revenue from the Medical Device segment.

Surmodics (STU:SU6) Headlines

No Headlines